Research on quaternary ammonium compounds (QACs) has shown their effectiveness in combating MRSA, a drug-resistant bacterium. Studies have demonstrated that QACs can effectively kill MRSA by disrupting its cell membranes. Researchers have utilized various methodologies, including in vitro experiments and animal studies, to investigate the antimicrobial properties of QACs against MRSA. The implications of these findings suggest that QACs could be a promising solution for combating MRSA infections, especially in healthcare settings where the bacterium is prevalent. Further research is needed to explore the potential of QACs as a viable treatment option for MRSA infections.